CompletedNot Applicable

PREMO Study: to Investigate Port REMoval Outcomes

Belgium100 participantsStarted 2019-06-28

Plain-language summary

A Totally Implantable Venous Access Device (TIVAD) that is no longer in use for intravenous therapy, should be flushed at established intervals to promote and maintain patency. No consensus has been established regarding the optimal duration of the interval between 2 maintenance sessions. This exploratory study will focus on catheter status under the current 3-monthly flush regimen.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients of 18 years and older, with a TIVAD that is no longer used for intravenous therapy on a regular basis for the past 365 days after completing initially planned treatment. * Patients planned for an elective TIVAD removal under local anaesthesia. * Patients able to participate in the study and willing to sign an informed consent. * Patients able to understand and read Dutch. Exclusion Criteria: • History of fever and/or chills following last flushing procedure

What they're measuring

TIVAD function

Timeframe: during the 1 day of TIVAD removal, before the linogram

Trial details

NCT IDNCT03948958

SponsorUniversitaire Ziekenhuizen KU Leuven

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-07-08

View on ClinicalTrials.gov More Neoplasms trials